ChemoCentryx, Inc.
Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
Last updated:
Abstract:
Benzimidazole, benzopyrazole and benzotriazole compounds are provided which bind to CCR(4) and are useful for the treatment of diseases such as allergic diseases, autoimmune diseases, graft rejection and cancer.
Status:
Grant
Type:
Utility
Filling date:
12 Sep 2017
Issue date:
12 May 2020